Knee osteoarthritis is a degenerative "wear and tear" disorder affecting mainly population over 50 years old. It can also present in younger people, especially after an injury or as a part of other diseases. While many therapeutic options exist for knee osteoarthritis, none of them has the potential to cure this condition. Cellular Matrix represents a combination of natural noncrosslinked hyaluronic acid (HA), thixotropic cell separation gel, and sodium citrate anticoagulant solution. A combination of Cellular Matrix with autologous platelet-rich plasma (A-PRP) is a novel therapeutic approach to the management of knee osteoarthritis. It is assumed that the active components HA and PRP have a synergistic effect contributing to a better therapeutic outcome in patients with knee osteoarthritis. Physiotherapy could provide an additional benefit. This is a retrospective pilot study assessing the potential benefit of Cellular Matrix and A-PRP combined with physiotherapy in the management of chronic knee osteoarthritis. Twenty-five patients were enrolled in the study and injected with three doses of Cellular Matrix combined with A-PRP with a time span of 2 weeks between each injection. All patients received standardized physiotherapy. The results showed that 68% of patients achieved more than 50% improvement in pain, stiffness, and function of the knee joints. There were no adverse reactions. This retrospective pilot study confirmed the positive effect of PRP and HA combination in the management of mild and moderate knee osteoarthritis. These preliminary results need to be verified in randomized control trials.
INTRODUCTION
Osteoarthritis (OA) is a common disease of the aged population. It is a progressive joint disease frequently affecting large weight-bearing joints, such as hips and knees. Mechanical stress in combination with biochemical factors contributes to the development of symptoms.
The prevalence of knee osteoarthritis is high compared to other types of osteoarthritis and younger obese women are a particularly vulnerable population (1) . A longer life span and higher body weight will probably increase the incidence of knee osteoarthritis in the future (2) .
Persisting knee pain, restricted function, sometimes followed by swelling and morning stiffness are the main features of the disease. Physical stress and joint deformities (genu varum and valgum) usually aggravate the condition (3) .
Treatment options include lifestyle modifications, pain management, and corticosteroid injections, with joint replacement reserved for those who have exhausted nonsurgical procedures.
Physical therapy has proved to be useful in helping patients with pain and mobility (4, 5) .
Analgesics and nonsteroidal anti-inflammatory drugs (NSAID) are most commonly prescribed for pain management, but their use can lead to many side effects (6, 7) .
High-quality studies confirmed the superiority of HA to placebo in patients with knee osteoarthritis (8) . Multiple studies have indicated that Platelet-rich plasma (PRP) is superior to hyaluronic acid and corticosteroids in terms of improving patient-reported pain and functionality scores. Current studies show promising potential of Cellular matrix in pain reduction and improvement of joint functions (9, 10) .
We conducted a retrospective, pilot study to test the hypothesis that Cellular matrix together with A-PRP and standard physical therapy (including hot packs, TENS, Quadriceps strengthening 4 exercises) is a safe procedure that improves pain and the functionality scores comparing to baseline values in patients with primary knee osteoarthritis.
MATERIALS AND METHODS
This is a retrospective, uncontrolled, case record study. It was conducted on a group of 25 patients diagnosed with primary knee osteoarthritis. Medical records were surveyed for inclusion and exclusion criteria and proceeded for analysis.
We included patients with grade 1-3 knee osteoarthritis using Kellgren and Lawrence system for classification of osteoarthritis of the knee (11) . Patients with grade 4 osteoarthritis and a history of trauma were excluded from the study. We also excluded patients with inflammatory rheumatologic disorders and patients who continued the regular use of non-steroidal antiinflammatory medications and pain killers. The patients were referred from primary health centers and from specialty clinics located in two hospitals.
Cellular matrix is described as a medical device containing natural, non-cross -linked HA, thixotropic separation gel and sodium citrate anticoagulant solution. The concentration of HA is 20 mg/ml (40 mg total) and quantity is 2 ml (12) . It is combined with autologous platelet-rich plasma prepared by drawing 10 ml blood from cubital vein and processing in a single spinning centrifuge machine. Intra-articular injections included three doses with a time span of two weeks between each dose. All patients received 10 sessions of standardized Physiotherapy Including hot packs, TENS and Quadriceps strengthening exercise. The treatment was conducted two times per week for 5 weeks. This study was approved by Dubai Scientific Research Ethics committee (Reference number DSREC-01/2019_05). 5 To provide an accurate result we applied WOMAC (The Western Ontario and McMaster Universities) test, version 3.1 Likert (13) . The test demonstrates the severity of the patient's condition in a range from none to extreme (none, mild, moderate, severe and extreme). It has a scoring system from zero to four. The maximal score that can be obtained is 96 and measuring include pain, stiffness, and function. The lower score presents better status, means score zero is the best and score ninety-six is the worst (14) .
Outcome measures

Interventions
Cellular Matrix intra-articular injections for all patients were conducted by the physician in the following way: the injection site was marked and cleaned with Betadine (povidone-iodine) solution for disinfection. After that, blood was drawn from the cubital vein into a syringe of 10ml. The blood was processed using a centrifuge machine to get high concentration of platelets in plasma (PRP). A nurse prepared the centrifuged cellular matrix for injection, then lidocaine injection (local anesthetic) was used to numb the injection site, and the doctor injects the cellular matrix combined with PRP into the knee joint. The same procedure is repeated two more times with 2 weeks duration between the previous dose and the following one. Patients were recommended to cease the use of NSAIDs one week before starting injections and during the whole treatment.
Statistical analysis
Statistical analysis was performed using GraphPad lnStat version 3.10, 32 bit for Windows, GraphPad Software, San Diego California USA, www.graphpad.com. P value is< 0.0001, considered extremely significant.
RESULTS
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There was a total number of 25 patients, 19 females (76%) and six males (24%), aged 39-76 years (mean: 57 years) ( Table 1) .
They were diagnosed with primary knee osteoarthritis grade 1-3 before starting treatment with Cellular Matrix combined with PRP. Twenty-four patients (96%) reported improvement in pain, stiffness, and function from the baseline measured by WOMAC score after 6 months. One patient (4%) showed a deterioration in pain, stiffness, and function after 6 months. Total 17 out of 25 (68%) patients showed more than 50% improvement in pain, stiffness, and function ( Table   2 ). Statistical analysis confirmed a significant improvement from the baseline at the level of P<0.001 (Table 3) .
DISCUSSION
There are numerous of studies investigated separate HA and A-PRP in treatment of knee osteoarthritis (15, 16, 17, 18) . However, studies including a combination of HA and PRP are very scarce. In one such case record studies, authors found that HA and PRP applied together provide statistically significant improvement in pain reduction, functional improvement, and quality of life 6 months after the treatment (19) . Our study showed similar results. The study published in 2015 compared cellular matrix and PRP with PRP alone in the treatment of mild and moderate knee osteoarthritis. The result showed that there is no difference in treatment outcome between these two procedures (20) .
So far, we did not find any study exploring the outcome of cellular matrix together with physiotherapy, so we are not able to compare results.
While the mechanism of action of PRP and Hyaluronic acid is already explained (21, 22) , it is not clear what is exactly the way of action when these two substances are applied together. We speculate that they might have a synergistic effect, but it has to be tested in randomized 7 controlled trials. The key factors that should be taken into consideration are a concentration of PRP from baseline, presence or absence of leucocytes and optimal molecular weight of hyaluronate.
Considering that this is a single-arm pilot study applied on small samples of patients, it is not possible to recommend cellular matrix combined with A-PRP as an advanced therapeutic option.
The main aim of this study was to test a safety profile and therapeutic effect in combination with physiotherapy. The study shows promising results because of a very high percentage of pain reduction and functional improvement without any significant adverse reactions. The patients selected for this study did not undergo regular radiological procedures, so we were not able to verify whether the clinical improvement was followed by any morphological changes detectable by magnetic resonance images.
A single-arm pilot study exploring the combination of cellular matrix combined with A-PRP, and physiotherapy showed promising results in the treatment of mild to moderate knee osteoarthritis. These results have to be verified in randomized controlled trials with larger samples of participants.
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